| scholarly article | Q13442814 |
| P2093 | author name string | Doe W | |
| Lawrance IC | |||
| Maxwell L | |||
| P2860 | cites work | Growth factors and cutaneous wound repair | Q35232541 |
| Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta | Q36352371 | ||
| Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts | Q41955517 | ||
| Skeletal muscle injury--molecular changes in the collagen during healing | Q50335738 | ||
| Detection of mrnas in sea urchin embryos by in situ hybridization using asymmetric RNA probes. | Q52276254 | ||
| P433 | issue | 1 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 16-26 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine | |
| P478 | volume | 7 |
| Q81439353 | Altered expression of type I insulin-like growth factor receptor in Crohn's disease |
| Q43010902 | Basement membrane components |
| Q98564930 | Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease |
| Q37951110 | Candidate mucosal and surrogate biomarkers of inflammatory bowel disease in the era of new technology |
| Q38259227 | Cellular and Molecular Mediators of Intestinal Fibrosis |
| Q33678275 | Chronic inflammation and cytokines in the tumor microenvironment |
| Q35951975 | Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis |
| Q43947507 | Crohn's disease and smoking: is it ever too late to quit? |
| Q58694446 | Cytokine Networks in Ulcerative Colitis |
| Q44206690 | Development of Fibrosis in Acute and Longstanding Ulcerative Colitis |
| Q37349705 | Differentiation and homing of IgA-secreting cells |
| Q33377579 | Disturbances in metabolic, transport and structural genes in experimental colonic inflammation in the rat: a longitudinal genomic analysis |
| Q37231304 | Endogenous IGF-I and alpha v beta3 integrin ligands regulate increased smooth muscle growth in TNBS-induced colitis |
| Q57610611 | Enhanced expression of transforming growth factor-?1 in inflammatory cells and secretory granules in Paneth cells in the small intestine of mice infected with Toxocara canis |
| Q37367619 | Functional role of eosinophils in gastrointestinal inflammation |
| Q50579974 | Glutamine prevents fibrosis development in rats with colitis induced by 2,4,6-trinitrobenzene sulfonic acid |
| Q35997118 | Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I. |
| Q46038277 | Halofuginone, a specific inhibitor of collagen type 1 synthesis, ameliorates oxidant colonic damage in rats with experimental colitis. |
| Q43130006 | Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease. |
| Q39825248 | High expression of HSP47 in ulcerative colitis-associated carcinomas: proteomic approach |
| Q42462619 | IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells |
| Q36769500 | Immune dysfunction in inflammatory bowel disease |
| Q90385665 | Immunological roles of intestinal mesenchymal cells |
| Q41828636 | Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1. |
| Q35672234 | Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-induced breast cancer cell proliferation and migration |
| Q38293779 | Mechanisms of initiation and progression of intestinal fibrosis in IBD. |
| Q37828318 | Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention |
| Q38940592 | MicroRNAs and Inflammation in Colorectal Cancer |
| Q48178964 | Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease. |
| Q45096816 | Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1. |
| Q53625989 | Prostaglandin E₂ and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function. |
| Q35062310 | Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease |
| Q37724676 | Resveratrol inhibits collagen I synthesis by suppressing IGF-1R activation in intestinal fibroblasts |
| Q35596217 | Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents |
| Q43065113 | Role of cytokines in inflammatory bowel disease |
| Q37789682 | Role of transforming growth factor-β in inflammatory bowel disease and colitis-associated colon cancer. |
| Q33890504 | Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis |
| Q35587152 | Serum laminin and collagen IV in inflammatory bowel disease |
| Q44520884 | Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. |
| Q57162849 | Serum type XVI collagen is associated with colorectal cancer and ulcerative colitis indicating a pathological role in gastrointestinal disorders |
| Q34013157 | Smad3 knock-out mice as a useful model to study intestinal fibrogenesis |
| Q34254416 | Substance P Modulates Colitis-Asscociated Fibrosis |
| Q37729715 | TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells |
| Q34778411 | The gut microbiome in intestinal fibrosis: environmental protector or provocateur? |
| Q36629839 | The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children. |
| Q42733498 | Themes in fibrosis and gastrointestinal inflammation |
| Q41993682 | Transforming growth factor-beta 1 induces intestinal myofibroblast differentiation and modulates their migration |
| Q46685848 | Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. |
| Q37160876 | Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats |
| Q38769875 | Will novel oral formulations change the management of inflammatory bowel disease? |
Search more.